Intellectual Property
Apr. 7, 2001
Bristol-Myers Drops Patent Fight for Chemo Drug
Pharmaceutical giant Bristol-Myers Squibb Co. has dropped its appeal of a case it brought against an Irvine-based manufacturer of generic drugs, removing a cloud hanging over the chemotherapy drug cisplatin.
Late last month, the U.S. Circ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In